Dupont Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Dupont Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,769	Closed	-$122K	–	1470
2022 Q3	$122K	Buy	+2,769	New	+$117K	0.01%	980
2020 Q3	–	Sell	-818	Closed	-$48K	–	1357
2020 Q2	$48K	Buy	+818	New	+$45.5K	﹤0.01%	1320
2018 Q2	–	Sell	-7,901	Closed	-$348K	–	1005
2018 Q1	$348K	Hold	7,901	–	–	0.01%	737
2017 Q4	$397K	Hold	7,901	–	–	0.01%	707
2017 Q3	$401K	Buy	7,901 +2,717	+52%	+$142K	0.01%	719
2017 Q2	$264K	Hold	5,184	–	–	0.01%	783
2017 Q1	$208K	Sell	5,184 -5,603	-52%	-$252K	﹤0.01%	809
2016 Q4	$516K	Buy	+10,787	New	+$427K	0.01%	646
2015 Q3	–	Sell	-19,887	Closed	-$1.14M	–	613
2015 Q2	$1.14M	Sell	19,887 -2,370	-11%	-$151K	0.02%	420
2015 Q1	$1.42M	Buy	22,257 +2,370	+12%	+$161K	0.03%	412
2014 Q4	$1.23M	Sell	19,887 -8,350	-30%	-$412K	0.02%	441
2014 Q3	$1.1M	Hold	28,237	–	–	0.02%	446
2014 Q2	$973K	Hold	28,237	–	–	0.02%	503
2014 Q1	$1.22M	Hold	28,237	–	–	0.02%	467
2013 Q4	$1.13M	Buy	+28,237	New	+$1.01M	0.02%	484

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dupont Capital Management's IONS Position: Q4 2022 in Review

Dupont Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 2,769 shares — an estimated $122K sold.

Dupont Capital Management first reported a position in IONS in Q4 2013 and held it in 15 quarters. The position peaked at $1.42M in Q1 2015. 338 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

Dupont Capital Management reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Dupont Capital Management sold 2,769 Ionis Pharmaceuticals shares in Q4 2022, an estimated $122K.
Dupont Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2013 and held it in 15 quarters.
Dupont Capital Management's Ionis Pharmaceuticals position peaked at $1.42M in Q1 2015.
338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.